BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 30915081)

  • 1. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
    Pilzecker B; Jacobs H
    Front Immunol; 2019; 10():438. PubMed ID: 30915081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes.
    Mayorov VI; Rogozin IB; Adkison LR; Frahm C; Kunkel TA; Pavlov YI
    BMC Immunol; 2005 Jun; 6():10. PubMed ID: 15949042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes.
    Bahjat M; Guikema JEJ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rev1 is essential in generating G to C transversions downstream of the Ung2 pathway but not the Msh2+Ung2 hybrid pathway.
    Krijger PH; Tsaalbi-Shtylik A; Wit N; van den Berk PC; de Wind N; Jacobs H
    Eur J Immunol; 2013 Oct; 43(10):2765-70. PubMed ID: 23857323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strikingly different properties of uracil-DNA glycosylases UNG2 and SMUG1 may explain divergent roles in processing of genomic uracil.
    Doseth B; Ekre C; Slupphaug G; Krokan HE; Kavli B
    DNA Repair (Amst); 2012 Jun; 11(6):587-93. PubMed ID: 22483865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA ubiquitination-independent activation of polymerase η during somatic hypermutation and DNA damage tolerance.
    Krijger PH; van den Berk PC; Wit N; Langerak P; Jansen JG; Reynaud CA; de Wind N; Jacobs H
    DNA Repair (Amst); 2011 Oct; 10(10):1051-9. PubMed ID: 21889916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.
    Pham P; Bransteitter R; Petruska J; Goodman MF
    Nature; 2003 Jul; 424(6944):103-7. PubMed ID: 12819663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of antibody somatic hypermutation.
    Di Noia JM; Neuberger MS
    Annu Rev Biochem; 2007; 76():1-22. PubMed ID: 17328676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymerases β and λ do not directly affect Ig variable region somatic hypermutation although their absence reduces the frequency of mutations.
    Schrader CE; Linehan EK; Ucher AJ; Bertocci B; Stavnezer J
    DNA Repair (Amst); 2013 Dec; 12(12):1087-93. PubMed ID: 24084171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
    Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
    DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Ig gene hypermutation in Ung(-/-)Polh(-/-) mice suggests that UNG and A:T mutagenesis pathway target different U:G lesions.
    Li S; Zhao Y; Wang JY
    Mol Immunol; 2013 Mar; 53(3):214-7. PubMed ID: 22960197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin Class Switch Recombination Is Initiated by Rare Cytosine Deamination Events at Switch Regions.
    Kim A; Han L; Yu K
    Mol Cell Biol; 2020 Jul; 40(16):. PubMed ID: 32513818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation patterns at Ig and Non-Ig Loci.
    Steele EJ; Franklin A; Lindley RA
    DNA Repair (Amst); 2024 Jan; 133():103607. PubMed ID: 38056368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repertoire Sequencing of B Cells Elucidates the Role of UNG and Mismatch Repair Proteins in Somatic Hypermutation in Humans.
    IJspeert H; van Schouwenburg PA; Pico-Knijnenburg I; Loeffen J; Brugieres L; Driessen GJ; Blattmann C; Suerink M; Januszkiewicz-Lewandowska D; Azizi AA; Seidel MG; Jacobs H; van der Burg M
    Front Immunol; 2019; 10():1913. PubMed ID: 31507588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced cytidine deaminase in antibody diversification and chromosome translocation.
    Gazumyan A; Bothmer A; Klein IA; Nussenzweig MC; McBride KM
    Adv Cancer Res; 2012; 113():167-90. PubMed ID: 22429855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Constitutive Fusion of Ubiquitin to PCNA Restores the Level of Immunoglobulin A/T Mutations During Somatic Hypermutation in the Ramos Cell Line.
    Lerner LK; Bonte D; Le Guillou M; Mohammad MM; Kasraian Z; Sarasin A; Despras E; Aoufouchi S
    Front Immunol; 2022; 13():871766. PubMed ID: 35432321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AID: how does it aid antibody diversity?
    Honjo T; Muramatsu M; Fagarasan S
    Immunity; 2004 Jun; 20(6):659-68. PubMed ID: 15189732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uracil in DNA--general mutagen, but normal intermediate in acquired immunity.
    Kavli B; Otterlei M; Slupphaug G; Krokan HE
    DNA Repair (Amst); 2007 Apr; 6(4):505-16. PubMed ID: 17116429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.